Erratum to “Systematic review of the use of intravenous amiodarone and nifekalant for cardiopulmonary resuscitation in Japan” [J. Arrhythm. 30 (2014) 180–185]
Main Authors: | Mari Amino, MD, PhD, Koichiro Yoshioka, MD, PhD, Shigetaka Kanda, MD, Yoshiaki Deguchi, MD, PhD, Mari Nakamura, MD, Yoshinori Kobayashi, MD, PhD, Sadaki Inokuchi, MD, PhD, Teruhisa Tanabe, MD, PhD, Yuji Ikari, MD, PhD |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2014-10-01
|
Series: | Journal of Arrhythmia |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1880427614001483 |
Similar Items
-
Systematic review of the use of intravenous amiodarone and nifekalant for cardiopulmonary resuscitation in Japan
by: Mari Amino, MD, PhD, et al.
Published: (2014-06-01) -
The usefulness of nifekalant for activation mapping of premature beat-triggered atrial fibrillation: Suppression of atrial fibrillation initiation without inhibiting premature beat
by: Masaharu Masuda, MD, et al.
Published: (2014-12-01) -
Efficacy of a pure Ikr blockade with nifekalant in refractory neonatal congenital junctional ectopic tachycardia and careful attention to damaging the atrioventricular conduction during the radiofrequency catheter ablation in infancy
by: Hisaaki Aoki, MD, PhD, et al.
Published: (2017-06-01) -
Smoking history and underlying lung disease are associated with poor outcome in patients developing interstitial pneumonia during low-dose amiodarone therapy
by: Masatsugu Nozoe, MD, PhD, et al.
Published: (2013-02-01) -
Safety and Efficacy of Amiodarone in a Patient With COVID-19
by: Nadia Castaldo, MD, et al.
Published: (2020-07-01)